Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization

PartnershipPositive

AI Analysis

Summary

Bio-Techne and Refeyn announced an integrated workflow combining icIEF fractionation and mass photometry for bispecific antibody and biosimilar characterization, reducing development time to four hours and accelerating biosimilar manufacturing.

Importance:5/10

Sentiment:

0.60

bispecific antibodiesbiosimilarscharacterizationmass photometryicIEFpartnershipanalytical workflow

Related Companies

$INBP

Read the original article

Published by PR Newswire Biotech on June 4, 2026 10:30 AM

Read Original